Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition

Virology

Volumn 409, Issue 1, 2011, Pages 113-120

  Tareen, Semih U ^a,b   Emerman, Michael ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Innate immunity; NF kappaB; Restriction; Retrovirus; TAB2; Trim30; Trim5; Trim5 ; Tripartite motif

Indexed keywords

ADAPTOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN TAB2; PROTEIN TAB3; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG;

ARTICLE; CONSERVATION GENETICS; CONTROLLED STUDY; GENE FUNCTION; GENE LOCUS; GENE TARGETING; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; RETROVIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS CAPSID; VIRUS CELL INTERACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CAPSID; CAPSID PROTEINS; CARRIER PROTEINS; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; MICE; NF-KAPPA B; RETROVIRIDAE;

MAMMALIA; MIRIDAE; PRIMATES; RODENTIA;

EID: 78649442925     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.09.018     Document Type: Article

References (34)

1. Bowie A.G. TRIM-ing down tolls. Nat. Immunol. 2008, 9:348-350.
2. Boxus M., Twizere J.C., Legros S., Dewulf J.F., Kettmann R., Willems L. The HTLV-1 tax interactome. Retrovirology 2008, 5:76.
3. Chen Z.J. Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol. 2005, 7:758-765.
4. Chen Z.J., Bhoj V., Seth R.B. Ubiquitin, TAK1 and IKK: is there a connection?. Cell Death Differ. 2006, 13:687-692.
5. Cheung P.C., Nebreda A.R., Cohen P. TAB3, a new binding partner of the protein kinase TAK1. Biochem. J. 2004, 378:27-34.
6. Delaney J.R., Mlodzik M. TGF-beta activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity. Cell Cycle 2006, 5:2852-2855.
7. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
8. Holmes E.C. Adaptation and immunity. PLoS Biol. 2004, 2:E307.
9. Johnson W.E., Sawyer S.L. Molecular evolution of the antiretroviral TRIM5 gene. Immunogenetics 2009, 61:163-176.
10. Liu H.L., Wang Y.Q., Liao C.H., Kuang Y.Q., Zheng Y.T., Su B. Adaptive evolution of primate TRIM5alpha, a gene restricting HIV-1 infection. Gene 2005, 362:109-116.
11. McEwan W.A., Schaller T., Ylinen L.M., Hosie M.J., Towers G.J., Willett B.J. Truncation of TRIM5 in the feliformia explains the absence of retroviral restriction in cells of the domestic cat. J. Virol. 2009, 83:8270-8275.
12. Mische C.C., Javanbakht H., Song B., Diaz-Griffero F., Stremlau M., Strack B., et al. Retroviral restriction factor TRIM5alpha is a trimer. J. Virol. 2005, 79:14446-14450.
13. Nisole S., Stoye J.P., Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 2005, 3:799-808.
14. O'Connor C., Pertel T., Gray S., Robia S.L., Bakowska J.C., Luban J., Campbell E.M. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha. J. Virol. 2010, 84:5997-6006.
15. Perez-Caballero D., Hatziioannou T., Yang A., Cowan S., Bieniasz P.D. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J. Virol. 2005, 79:8969-8978.
16. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., et al. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20:2140-2151.
17. Rold C.J., Aiken C. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog. 2008, 4:e1000074.
18. Sawyer S.L., Wu L.I., Emerman M., Malik H.S. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc. Natl. Acad. Sci. USA 2005, 102:2832-2837.
19. Sawyer S.L., Wu L.I., Akey J.M., Emerman M., Malik H.S. High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans. Curr. Biol. 2006, 16:95-100.
20. Sawyer S.L., Emerman M., Malik H.S. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog. 2007, 3:e197.
21. Schaller T., Hue S., Towers G.J. An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins. J. Virol. 2007, 81:11713-11721.
22. Sebastian S., Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005, 2:40.
23. Shi M., Deng W., Bi E., Mao K., Ji Y., Lin G., et al. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 2008, 9:369-377.
24. Shim J.H., Xiao C., Paschal A.E., Bailey S.T., Rao P., Hayden M.S., et al. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005, 19:2668-2681.
25. Si Z., Vandegraaff N., O'huigin C., Song B., Yuan W., Xu C., et al. Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc. Natl. Acad. Sci. USA 2006, 103:7454-7459.
26. Skaug B., Jiang X., Chen Z.J. The role of ubiquitin in NF-kappaB regulatory pathways. Annu. Rev. Biochem. 2009, 78:769-796.
27. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old world monkeys. Nature 2004, 427:848-853.
28. Suzuki S., Singhirunnusorn P., Mori A., Yamaoka S., Kitajima I., Saiki I., et al. Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-kappaB. J. Biol. Chem. 2007, 282:25177-25181.
29. Takaesu G., Kishida S., Hiyama A., Yamaguchi K., Shibuya H., Irie K., et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol. Cell 2000, 5:649-658.
30. Tareen S.U., Sawyer S.L., Malik H.S., Emerman M. An expanded clade of rodent Trim5 genes. Virology 2009, 385:473-483.
31. Towers G.J. Control of viral infectivity by tripartite motif proteins. Hum. Gene Ther. 2005, 16:1125-1132.
32. Wang X., Li M., Zheng H., Muster T., Palese P., Beg A.A., et al. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J. Virol. 2000, 74:11566-11573.
33. Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N., et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 1995, 270:2008-2011.
34. Yu Q., Minoda Y., Yoshida R., Yoshida H., Iha H., Kobayashi T., et al. HTLV-1 tax-mediated TAK1 activation involves TAB2 adapter protein. Biochem. Biophys. Res. Commun. 2008, 365:189-194.